Implementing good participatory practice guidelines in the FEM-PrEP Preexposure Prophylaxis Trial for HIV Prevention among African Women: A focus on local stakeholder involvement

Open Access Journal of Clinical Trials

Volumn 5, Issue 1, 2012, Pages 127-135

  Mack, Natasha ^a   Kirkendale, Stella ^a   Omullo, Paul ^b   Odhiambo, Jacob ^b   Ratlhagana, Malebo ^c   Masaki, Martha ^d   Siguntu, Phumzile ^e   Agot, Kawango ^b   Ahmed, Khatija ^c   Kapiga, Saidi ^d   Lombaard, Johan ^e   Van Damme, Lut ^a   Corneli, Amy ^a  

^a FAMILY HEALTH INTERNATIONAL   (United States)

^b IMPACT RESEARCH AND DEVELOPMENT ORGANIZATION   (Kenya)

^c Setshaba Research Centre   (South Africa)

^d KILIMANJARO CHRISTIAN MEDICAL CENTRE   (Tanzania)

^e JOSHA Research   (South Africa)

Author keywords

Community engagement; Community involvement; FEM PrEP; Good participatory practice guidelines; HIV prevention trials; Stakeholder engagement

Indexed keywords

AFRICA; ARTICLE; COMMUNITY PROGRAM; COOPERATION; HEALTH CARE NEED; HEALTH PROGRAM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION PREVENTION; INFORMATION DISSEMINATION; MEDICAL ETHICS; PARTICIPATORY MANAGEMENT; PRACTICE GUIDELINE; PROGRAM DEVELOPMENT; STRATEGIC PLANNING; TREATMENT PLANNING; VIRUS TRANSMISSION; WOMEN'S HEALTH;

EID: 84889860596     PISSN: None     EISSN: 11791586     Source Type: Journal    
DOI: 10.2147/OAJCT.S45717     Document Type: Article

References (18)

1. McGrory E, Irvin A, Heise L. Research Rashomon: Lessons Learned from the Cameroon Pre-exposure Prophylaxis Trial Site. Seattle: Program for Appropriate Technology in Health; 2009.
2. Singh JA, Mills EJ. The abandoned trials of pre-exposure prophylaxis for HIV: what went wrong? PLoS Med. 2005;2(9):e234.
3. Mills E, Rachlis B, Wu P, Wong E, Wilson K, Singh S. Media reporting of tenofovir trials in Cambodia and Cameroon. BMC Int Health Hum Rights. 2005;5:6.
4. Page-Shafer K, Saphonn V, Sun LP, Vun MC, Cooper DA, Kaldor JM. HIV prevention research in a resource-limited setting: the experience of planning a trial in Cambodia. Lancet. 2005;366(9495):1499-1503.
5. Mack N, Robinson ET, MacQueen KM, Moffett J, Johnson LM. The exploitation of "Exploitation" in the tenofovir prep trial in Cameroon: lessons learned from media coverage of an HIV prevention trial. J Empir Res Hum Res Ethics. 2010;5(2):3-19.
6. Joint United Nations Programme on HIV/AIDS. Good Participatory Practice: Guidelines for Biomedical HIV Prevention Trials. Geneva: UNAIDS; 2011.
7. Robinson E, Baron D, Heise L, Moffett J, Harlan S. Communications Handbook for Clinical Trials. Seattle: Program for Appropriate Technology in Health; 2010.
8. Van Damme L, Corneli A, Ahmed K, etal. Preexposure prophylaxis for HIV infection among African women. N Engl J Med. 2012;367(5): 411-422.
9. Rivera R, Borasky D, Carayon F, etal. Research Ethics Training Curriculum for Community Representatives. Durham (NC): Family Health International; 2004.
10. Minkler M, Blackwell AG, Thompson M, Tamir H. Community-based participatory research: implications for public health funding. Am J Public Health. 2003;93(8):1210-1213.
11. Minkler M. Ethical challenges for the "outside" researcher in community-based participatory research. Health Educ Behav. 2004;31(6):684-697.
12. Ellen JM, Wallace M, Sawe FK, Fisher K. Community engagement and investment in biomedical HIV prevention research for youth: rationale, challenges, and approaches. J Acquir Immune Defic Syndr. 2010;54 Suppl 1:S7-S11.
13. MacQueen KM, Cates W Jr. The multiple layers of prevention science research. Am J Prev Med. 2005;28(5):491-495.
14. Shagi C, Vallely A, Kasindi S, etal. A model for community representation and participation in HIV prevention trials among women who engage in transactional sex in Africa. AIDS Care. 2008;20(09): 1039-1049.
15. Morin SF, Maiorana A, Koester KA, Sheon NM, Richards TA. Community consultation in HIV prevention research: a study of community advisory boards at 6 research sites. J Acquir Immune Defic Syndr. 2003;33(4):513-520.
16. Strauss RP, Sengupta S, Quinn SC, etal. The role of community advisory boards: involving communities in the informed consent process. Am J Public Health. 2001;91(12):1938-1943.
17. White R, Chileshe M, Dawson L, etal. Fostering community understanding of sufficient benefit and early stopping for a phase 2B HIV prevention clinical trial in Africa. Clin Trials. 2011;8(1):103-111.
18. Chung K, Lounsbury DW. The role of power, process, and relationships in participatory research for statewide HIV/AIDS programming. Soc Sci Med. 2006;63(8):2129-2140.